Microbiological Assay of Two Selected Products of Ceftriaxone Powder for Injection from Pharmaceuticals' Market in Sudan

Authors

  • Idries AM Department of Pharmaceutical Analysis, Faculty of Pharmacy, University of Khartoum, Sudan
  • Ibrahim KE Department of Pharmaceutical Analysis, Faculty of Pharmacy, University of Khartoum, Sudan

DOI:

https://doi.org/10.52981/sjms.v9i4.1293

Keywords:

Microbiological assay, Ceftriaxone, relative potency and genericmedicines.

Abstract

Background: Different techniques have classically been used to evaluate and assure the quality of medicines circulated on the market; one of the commonly uses is chemical analysis. However, some evidence has shown that there are other important indicators (e.g. bioequivalence, relative potency, etc.) that should also be considered when evaluating the quality of pharmaceutical products.
Materials and Methods: A microbiological assay was conducted to compare the relative potency of two Ceftriaxone products (with a third one used as standard product) from the market using 3 reference bacteria including Streptococcus pneumoniae, Klebsiella pneumoniae and Staphylococcus aureus. Serial dilutions were made with the corresponding 1, 4, 8, 16 and 32-fold Minimum Inhibitory Concentration (MIC) of Ceftriaxone against the bacteria under investigation.
Results: The relative potency of one product compared to the standard product was estimated to be within the acceptable range of bioequivalence (89.6%), while the other product showed unacceptable relative potency (72.3%).
Conclusions: The microbiological assay is an effective and simple method for comparing the equivalency of injectable products. A complaint reporting system about quality and effectiveness problems needs to be considered as a priority source of such information to inform decision-makers.

References

1. World Health Organization. Marketing authorisation of pharmaceutical products with special reference to multisource (generic) products 1999.
2. Zuluaga, A. F., et al. Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics. BMC Clinical Pharmacology 2009; 1: 6904-9.
3. Palmer, S. M., et al. Bactericidal killing activities of Cefepime, Ceftazidime, Cefotaxime, and Ceftriaxone against selected microorganisms in an in vitro infection model. Antimicrobial Agents and Chemotherapy 1995; 2: 1764–1771.
4. Murray, P. R. Manual of Clinical Microbiology (9 ed.). ASM. 2007.
5. Simon, H., & Yin, E. Microbioassay of antimicrobial agents. Applied Microbiology 1970; 1: 573-579.
6. Humphrey, J., & Lightbown, J. A general theory for plate assay of antibiotics with some practical applications. Journal of General Microbiology 1992; 1: 129-143.
7. Layloff, T. The importance of analytical procedures in regulatory control. WHO Drug Information 1997; 11(3): 128-131.

Downloads

Published

2021-08-23

Issue

Section

Original Articles